Mangafodipir as a cytoprotective adjunct to chemotherapy – a case report

Figures & data

Table I.  Hematological and biochemical findings. Median value and range for different parameters derived from all blood samples taken during the FLOX treatment. ALAT: Alanine transaminase; ASAT: Aspartate transaminase; GT: Gamma-glutamyl transferase; CRP: C-reactive protein; CEA: Carcinoembryonic antigen.

Parameter (normal limits)	Median value (range)
Hemoglobin (13.4–17.0 g/dl)	13.0 (10.7–15.2)
Total white blood cell count (3.5–8.8×109/l)	13.4 (8.0–28.2)
Total platelet count (145–348×109/l)	216 (146–637)
Neutrophiles (1.3–5.1×109/l)	8.3 (4.4–22.4)
Total bilirubin (5–25 µmol/l)	195 (43–295)
Creatinine (60–105 µmol/l)	42 (28–59)
ASAT (15–45 U/l)	109 (48–196)
ALAT (10–70 U/l)	65 (37–129)
Lactate dehydrogenase (105–205 U/l)	164 (111–283)
GT (10–80 U/l)	408 (187–1072)
Alkaline phosphatase (35–105 U/l)	346 (231–779)
CRP (0–5 mg/l)	42 (15–103)
Total albumin (36–48 g/l)	23 (12–30)
CEA (0–5 µmol/l)	8 (5–19)